title: Comment on: "clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 Study)".
authors.affiliation: Department of Radiation Oncology, Stanford University, Stanford, California, USA.
authors.forename: Richard
authors.initials: R
authors.lastname: Hoppe
authors.affiliation: Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
authors.forename: Tim
authors.initials: T
authors.lastname: Illidge
authors.affiliation: Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
authors.forename: Lena
authors.initials: L
authors.lastname: Specht
authors.affiliation: Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
authors.forename: Ivan
authors.initials: I
authors.lastname: Vogelius
authors.affiliation: Department of Radiation Oncology, Memorial-Sloan Kettering Cancer Center, New York, New York, USA.
authors.forename: Joachim
authors.initials: J
authors.lastname: Yahalom
mesh_terms: D001859:Bone Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000532:radiotherapy*; D008297:Male